I agree that this site is using cookies. You can find further informations here.
X
Noort, V.v.d.
352  results:
Search for persons X
?
1

OA04.06 PEMbrolizumab Plus Lenvatinib In Second And Third L..:

Douma, L.-A.H. ; de Gooijer, C.J. ; Noort, V.v.d....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S13 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Optimising primary molecular profiling in non-small cell lu..:

Schouten, R. D. ; Schouten, I. ; Schuurbiers, M. M. F....
PLOS ONE.  19 (2024)  7 - p. e0290939 , 2024
Link: https://doi.org/10.1371/..
 
?
3

Omission of axillary lymph node dissection in cN2-3 breast ..:

van Hemert, A. ; van Loevezijn, A.A. ; Baas, M.S.P.D....
European Journal of Cancer.  200 (2024)  - p. 113618 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Combined Cabazitaxel and Carboplatin Treatment of Metastati..:

van der Zande, K. ; Tutuhatunewa-Louhanepessy, R.D. ; Hamberg, P....
Clinical Genitourinary Cancer.  22 (2024)  2 - p. 445-453.e1 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Nivolumab and ipilimumab in the real-world setting in patie..:

Dumoulin, D.W. ; Douma, L.H. ; Hofman, M.M....
Lung Cancer.  187 (2024)  - p. 107440 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Histopathological concordance between prostate biopsies and..:

Hagens, M. J. ; Ribbert, L. L. A. ; Jager, A....
Prostate Cancer and Prostatic Diseases.  27 (2023)  2 - p. 312-317 , 2023
Link: https://doi.org/10.1038/..
 
?
7

Histopathological Concordance between Prostate Biopsies and..:

Hagens, M.J. ; Ribbert, L.L.A. ; Jager, A....
European Urology Open Science.  57 (2023)  - p. S60-S61 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Trastuzumab-Emtansine and Osimertinib Combination Therapy t..:

Jebbink, M. ; de Langen, A.J. ; Monkhorst, K....
JTO Clinical and Research Reports.  4 (2023)  4 - p. 100481 , 2023
Link: https://doi.org/10.1016/..
 
?
9

99P The optimal treatment for patients with stage I non-sma..:

de Ruiter, J. ; van der Noort, V. ; van Diessen, J....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S98 , 2023
Link: https://doi.org/10.1016/..
 
?
10

The successful patient-preference design for the LORD-trial..:

Schmitz, R. ; Sondermeijer, C. ; van der Noort, V....
European Journal of Cancer.  175 (2022)  - p. S3-S4 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Oncological outcomes of sentinel lymph node procedure-based..:

De Barros, H.A. ; Grivas, N. ; Duin, J.J....
European Urology.  81 (2022)  - p. S996-S997 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Can serum human epididymis protein 4 (HE4) support the deci..:

Lof, P. ; van de Vrie, R. ; Korse, C.M....
Gynecologic Oncology.  , 2022
Link: https://doi.org/10.1016/..
 
?
13

T007 Serum CEA- and Cyfra 21.1-response based tests enable ..:

Muller, M. ; Hoogendoorn, R. ; Moritz, R....
Clinica Chimica Acta.  530 (2022)  - p. S51-S52 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Limiting systemic endocrine overtreatment in postmenopausal..:

Opdam, M. ; van der Noort, V. ; Kleijn, M....
Breast Cancer Research and Treatment.  194 (2022)  2 - p. 265-278 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Trastuzumab and pertuzumab combination therapy for advanced..:

van Berge Henegouwen, J.M. ; Jebbink, M. ; Hoes, L.R....
European Journal of Cancer.  171 (2022)  - p. 114-123 , 2022
Link: https://doi.org/10.1016/..
 
1-15